NVCR Market Cap History



Below is a table of the NVCR market cap history going back to 10/2/2015:

Date NVCR Market Cap
10/2/20151.51B
10/22/20151.60B
2/26/2016943.05M
5/6/20161.06B
7/26/2016995.85M
10/27/2016537.17M
2/16/2017661.75M
4/20/20171.02B
7/20/20171.68B
10/19/20171.62B
2/16/20181.93B
4/19/20182.27B
7/19/20183.47B
10/18/20184.19B
2/21/20195.07B
4/25/20194.31B
7/18/20196.97B
10/23/20196.95B
2/19/20209.54B
4/23/20207.34B
7/23/20206.85B
10/23/202012.60B
2/22/202118.54B
4/23/202121.47B
7/23/202119.63B
10/22/202112.54B
2/21/20227.94B
4/22/20228.28B
7/22/20227.52B
10/21/20227.62B
2/20/20238.94B
4/28/20237.00B
7/21/20234.15B
10/20/20231.56B
2/16/20241.73B

Also see: NVCR Shares Outstanding History
and NVCR YTD Return
NVCR Historical Market Cap:
+1.61% CAGR
NVCR Historical Market Cap: +1.61% CAGR

Mouse over chart for data details
10/2/2015 ...2/16/2024
NovoCure is an oncology company with a platform technology called Tumor Treating Fields. Co. is focusing on commercial adoption of Optune and NovoTTF-100L. Optune is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with newly diagnosed glioblastoma (GBM) in combination with temozolomide, a chemotherapy drug, and for adult patients with GBM following confirmed recurrence after chemotherapy as monotherapy treatment. Co. also has approval to market Optune for the treatment of GBM in the European Union, Japan and certain other countries. NovoTTF-100L is approved by the FDA to treat malignant pleural mesothelioma in combination with chemotherapies. We show 35 historical shares outstanding datapoints in our NVCR shares outstanding history coverage, used to compute NVCR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NVCR market cap history over the course of time is important for investors interested in comparing NVCR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NVCR versus a peer is one thing; comparing NVCR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NVCR can fluctuate over the course of history. With this page we aim to empower investors researching NVCR by allowing them to research the NVCR market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NVCR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
NovoCure (NVCR) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NVEI Market Cap History
NVGS Market Cap History
NVLN Market Cap History
NVSA Market Cap History
NVTS Market Cap History
NWTN Market Cap History
NYAX Market Cap History
NYXH Market Cap History
OACB Market Cap History
OAKU Market Cap History
More Miscellaneous companies »

 

NVCR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.